142 lines
56 KiB
Text
142 lines
56 KiB
Text
<!DOCTYPE html>
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" class="no-js no-jr">
|
|
<head>
|
|
<!-- For pinger, set start time and add meta elements. -->
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books">
|
|
<meta name="ncbi_pdid" content="book-part">
|
|
<meta name="ncbi_acc" content="NBK604921">
|
|
<meta name="ncbi_domain" content="nciprotocols">
|
|
<meta name="ncbi_report" content="reader">
|
|
<meta name="ncbi_type" content="fulltext">
|
|
<meta name="ncbi_objectid" content="">
|
|
<meta name="ncbi_pcid" content="/NBK604921/?report=reader">
|
|
<meta name="ncbi_pagename" content="Chemotaxis Assay - National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols - NCBI Bookshelf">
|
|
<meta name="ncbi_bookparttype" content="chapter">
|
|
<meta name="ncbi_app" content="bookshelf">
|
|
<!-- Logger end -->
|
|
|
|
<!--component id="Page" label="meta"/-->
|
|
<script type="text/javascript" src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.boots.min.js"> </script><title>Chemotaxis Assay - National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols - NCBI Bookshelf</title>
|
|
<meta charset="utf-8">
|
|
<meta name="apple-mobile-web-app-capable" content="no">
|
|
<meta name="viewport" content="initial-scale=1,minimum-scale=1,maximum-scale=1,user-scalable=no">
|
|
<meta name="jr-col-layout" content="auto">
|
|
<meta name="jr-prev-unit" content="/books/n/nciprotocols/ncipr47/?report=reader">
|
|
<meta name="jr-next-unit" content="/books/n/nciprotocols/ncipr45/?report=reader">
|
|
<meta name="bk-toc-url" content="/books/n/nciprotocols/?report=toc">
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE">
|
|
<meta name="citation_inbook_title" content="National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]">
|
|
<meta name="citation_title" content="Chemotaxis Assay">
|
|
<meta name="citation_publisher" content="National Cancer Institute (US)">
|
|
<meta name="citation_date" content="2020/05">
|
|
<meta name="citation_author" content="Timothy M. Potter">
|
|
<meta name="citation_author" content="Edward Cedrone">
|
|
<meta name="citation_author" content="Barry W. Neun">
|
|
<meta name="citation_author" content="Marina A. Dobrovolskaia">
|
|
<meta name="citation_pmid" content="39013052">
|
|
<meta name="citation_doi" content="10.17917/CPWX-SP39">
|
|
<meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK604921/">
|
|
<link rel="schema.DC" href="http://purl.org/DC/elements/1.0/">
|
|
<meta name="DC.Title" content="Chemotaxis Assay">
|
|
<meta name="DC.Type" content="Text">
|
|
<meta name="DC.Publisher" content="National Cancer Institute (US)">
|
|
<meta name="DC.Contributor" content="Timothy M. Potter">
|
|
<meta name="DC.Contributor" content="Edward Cedrone">
|
|
<meta name="DC.Contributor" content="Barry W. Neun">
|
|
<meta name="DC.Contributor" content="Marina A. Dobrovolskaia">
|
|
<meta name="DC.Date" content="2020/05">
|
|
<meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK604921/">
|
|
<meta name="description" content="This document provides a protocol for rapid, quantitative measure of the chemoattractant capacity of a nanoparticulate material. Leukocyte recruitment is a central component of the inflammatory process, both in physiological host defense and in a range of prevalent disorders with an inflammatory component. In response to a complex network of pro-inflammatory signaling molecules (including cytokines, chemokines and prostaglandins), circulating leukocytes migrate from the bloodstream to the site of inflammation.">
|
|
<meta name="og:title" content="Chemotaxis Assay">
|
|
<meta name="og:type" content="book">
|
|
<meta name="og:description" content="This document provides a protocol for rapid, quantitative measure of the chemoattractant capacity of a nanoparticulate material. Leukocyte recruitment is a central component of the inflammatory process, both in physiological host defense and in a range of prevalent disorders with an inflammatory component. In response to a complex network of pro-inflammatory signaling molecules (including cytokines, chemokines and prostaglandins), circulating leukocytes migrate from the bloodstream to the site of inflammation.">
|
|
<meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK604921/">
|
|
<meta name="og:site_name" content="NCBI Bookshelf">
|
|
<meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-nciprotocols-lrg.png">
|
|
<meta name="twitter:card" content="summary">
|
|
<meta name="twitter:site" content="@ncbibooks">
|
|
<meta name="bk-non-canon-loc" content="/books/n/nciprotocols/ncipr46/?report=reader">
|
|
<link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK604921/">
|
|
<link href="https://fonts.googleapis.com/css?family=Archivo+Narrow:400,700,400italic,700italic&subset=latin" rel="stylesheet" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/libs.min.css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/jatsreader/ptpmc_3.22/css/jr.min.css">
|
|
<meta name="format-detection" content="telephone=no">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css//books_print.min.css" type="text/css" media="print">
|
|
<link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_reader.min.css" type="text/css">
|
|
<style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} .body-content h2, .body-content .h2 {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list .graphic {display:inline-block !important} .temp-labeled-list img{width:100%}</style>
|
|
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico">
|
|
<meta name="ncbi_phid" content="CE8B5C3C7C8ED0910000000000380032.m_5">
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3849091.css"></head>
|
|
<body>
|
|
<!-- Book content! -->
|
|
|
|
|
|
<div id="jr" data-jr-path="/corehtml/pmc/jatsreader/ptpmc_3.22/"><div class="jr-unsupported"><table class="modal"><tr><td><span class="attn inline-block"></span><br />Your browser does not support the NLM PubReader view.<br />Go to <a href="/pmc/about/pr-browsers/">this page</a> to see a list of supported browsers<br />or return to the <br /><a href="/books/NBK604921/?report=classic">regular view</a>.</td></tr></table></div><div id="jr-ui" class="hidden"><nav id="jr-head"><div class="flexh tb"><div id="jr-tb1"><a id="jr-links-sw" class="hidden" title="Links"><svg xmlns="http://www.w3.org/2000/svg" version="1.1" x="0px" y="0px" viewBox="0 0 70.6 85.3" style="enable-background:new 0 0 70.6 85.3;vertical-align:middle" xml:space="preserve" width="24" height="24">
|
|
<style type="text/css">.st0{fill:#939598;}</style>
|
|
<g>
|
|
<path class="st0" d="M36,0C12.8,2.2-22.4,14.6,19.6,32.5C40.7,41.4-30.6,14,35.9,9.8"></path>
|
|
<path class="st0" d="M34.5,85.3c23.2-2.2,58.4-14.6,16.4-32.5c-21.1-8.9,50.2,18.5-16.3,22.7"></path>
|
|
<path class="st0" d="M34.7,37.1c66.5-4.2-4.8-31.6,16.3-22.7c42.1,17.9,6.9,30.3-16.4,32.5h1.7c-66.2,4.4,4.8,31.6-16.3,22.7 c-42.1-17.9-6.9-30.3,16.4-32.5"></path>
|
|
</g>
|
|
</svg> Books</a></div><div class="jr-rhead f1 flexh"><div class="head"><a href="/books/n/nciprotocols/ncipr47/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="body"><div class="t">NCL Method ITA-8.1, Chemotaxis Assay: Version 2</div><div class="j">National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]</div></div><div class="tail"><a href="/books/n/nciprotocols/ncipr45/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></div><div id="jr-tb2"><a id="jr-bkhelp-sw" class="btn wsprkl hidden" title="Help with NLM PubReader">?</a><a id="jr-help-sw" class="btn wsprkl hidden" title="Settings and typography in NLM PubReader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512" preserveAspectRatio="none"><path d="M462,283.742v-55.485l-29.981-10.662c-11.431-4.065-20.628-12.794-25.274-24.001 c-0.002-0.004-0.004-0.009-0.006-0.013c-4.659-11.235-4.333-23.918,0.889-34.903l13.653-28.724l-39.234-39.234l-28.72,13.652 c-10.979,5.219-23.68,5.546-34.908,0.889c-0.005-0.002-0.01-0.003-0.014-0.005c-11.215-4.65-19.933-13.834-24-25.273L283.741,50 h-55.484l-10.662,29.981c-4.065,11.431-12.794,20.627-24.001,25.274c-0.005,0.002-0.009,0.004-0.014,0.005 c-11.235,4.66-23.919,4.333-34.905-0.889l-28.723-13.653l-39.234,39.234l13.653,28.721c5.219,10.979,5.545,23.681,0.889,34.91 c-0.002,0.004-0.004,0.009-0.006,0.013c-4.649,11.214-13.834,19.931-25.271,23.998L50,228.257v55.485l29.98,10.661 c11.431,4.065,20.627,12.794,25.274,24c0.002,0.005,0.003,0.01,0.005,0.014c4.66,11.236,4.334,23.921-0.888,34.906l-13.654,28.723 l39.234,39.234l28.721-13.652c10.979-5.219,23.681-5.546,34.909-0.889c0.005,0.002,0.01,0.004,0.014,0.006 c11.214,4.649,19.93,13.833,23.998,25.271L228.257,462h55.484l10.595-29.79c4.103-11.538,12.908-20.824,24.216-25.525 c0.005-0.002,0.009-0.004,0.014-0.006c11.127-4.628,23.694-4.311,34.578,0.863l28.902,13.738l39.234-39.234l-13.66-28.737 c-5.214-10.969-5.539-23.659-0.886-34.877c0.002-0.005,0.004-0.009,0.006-0.014c4.654-11.225,13.848-19.949,25.297-24.021 L462,283.742z M256,331.546c-41.724,0-75.548-33.823-75.548-75.546s33.824-75.547,75.548-75.547 c41.723,0,75.546,33.824,75.546,75.547S297.723,331.546,256,331.546z"></path></svg></a><a id="jr-fip-sw" class="btn wsprkl hidden" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-rtoc-sw" class="btn wsprkl hidden" title="Table of Contents"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,20h10v8H20V20zM36,20h44v8H36V20zM20,37.33h10v8H20V37.33zM36,37.33h44v8H36V37.33zM20,54.66h10v8H20V54.66zM36,54.66h44v8H36V54.66zM20,72h10v8 H20V72zM36,72h44v8H36V72z"></path></svg></a></div></div></nav><nav id="jr-dash" class="noselect"><nav id="jr-dash" class="noselect"><div id="jr-pi" class="hidden"><a id="jr-pi-prev" class="hidden" title="Previous page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a><div class="pginfo">Page <i class="jr-pg-pn">0</i> of <i class="jr-pg-lp">0</i></div><a id="jr-pi-next" class="hidden" title="Next page"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div><div id="jr-is-tb"><a id="jr-is-sw" class="btn wsprkl hidden" title="Switch between Figures/Tables strip and Progress bar"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><rect x="10" y="40" width="20" height="20"></rect><rect x="40" y="40" width="20" height="20"></rect><rect x="70" y="40" width="20" height="20"></rect></svg></a></div><nav id="jr-istrip" class="istrip hidden"><a id="jr-is-prev" href="#" class="hidden" title="Previous"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M80,40 60,65 80,90 70,90 50,65 70,40z M50,40 30,65 50,90 40,90 20,65 40,40z"></path><text x="35" y="25" textLength="60" style="font-size:25px">Prev</text></svg></a><a id="jr-is-next" href="#" class="hidden" title="Next"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M20,40 40,65 20,90 30,90 50,65 30,40z M50,40 70,65 50,90 60,90 80,65 60,40z"></path><text x="15" y="25" textLength="60" style="font-size:25px">Next</text></svg></a></nav><nav id="jr-progress"></nav></nav></nav><aside id="jr-links-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">NCBI Bookshelf</div></div><div class="cnt lol f1"><a href="/books/">Home</a><a href="/books/browse/">Browse All Titles</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://www.facebook.com/sharer/sharer.php?u=https://www.ncbi.nlm.nih.gov/books/NBK604921/"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24" preserveAspectRatio="none"><g><path d="M 17.996,32L 12,32 L 12,16 l-4,0 l0-5.514 l 4-0.002l-0.006-3.248C 11.993,2.737, 13.213,0, 18.512,0l 4.412,0 l0,5.515 l-2.757,0 c-2.063,0-2.163,0.77-2.163,2.209l-0.008,2.76l 4.959,0 l-0.585,5.514L 18,16L 17.996,32z"></path></g></svg> Share on Facebook</a><a class="btn share" target="_blank" rel="noopener noreferrer" href="https://twitter.com/intent/tweet?url=https://www.ncbi.nlm.nih.gov/books/NBK604921/&text=Chemotaxis%20Assay"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 33 33" style="vertical-align:middle" width="24" height="24"><g><path d="M 32,6.076c-1.177,0.522-2.443,0.875-3.771,1.034c 1.355-0.813, 2.396-2.099, 2.887-3.632 c-1.269,0.752-2.674,1.299-4.169,1.593c-1.198-1.276-2.904-2.073-4.792-2.073c-3.626,0-6.565,2.939-6.565,6.565 c0,0.515, 0.058,1.016, 0.17,1.496c-5.456-0.274-10.294-2.888-13.532-6.86c-0.565,0.97-0.889,2.097-0.889,3.301 c0,2.278, 1.159,4.287, 2.921,5.465c-1.076-0.034-2.088-0.329-2.974-0.821c-0.001,0.027-0.001,0.055-0.001,0.083 c0,3.181, 2.263,5.834, 5.266,6.438c-0.551,0.15-1.131,0.23-1.73,0.23c-0.423,0-0.834-0.041-1.235-0.118 c 0.836,2.608, 3.26,4.506, 6.133,4.559c-2.247,1.761-5.078,2.81-8.154,2.81c-0.53,0-1.052-0.031-1.566-0.092 c 2.905,1.863, 6.356,2.95, 10.064,2.95c 12.076,0, 18.679-10.004, 18.679-18.68c0-0.285-0.006-0.568-0.019-0.849 C 30.007,8.548, 31.12,7.392, 32,6.076z"></path></g></svg> Share on Twitter</a></div></aside><aside id="jr-rtoc-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Table of Content</div></div><div class="cnt lol f1"><a href="/books/n/nciprotocols/?report=reader">Title Information</a><a href="/books/n/nciprotocols/toc/?report=reader">Table of Contents Page</a></div></aside><aside id="jr-help-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Settings</div></div><div class="cnt f1"><div id="jr-typo-p" class="typo"><div><a class="sf btn wsprkl">A-</a><a class="lf btn wsprkl">A+</a></div><div><a class="bcol-auto btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 200 100" preserveAspectRatio="none"><text x="10" y="70" style="font-size:60px;font-family: Trebuchet MS, ArialMT, Arial, sans-serif" textLength="180">AUTO</text></svg></a><a class="bcol-1 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M15,25 85,25zM15,40 85,40zM15,55 85,55zM15,70 85,70z"></path></svg></a><a class="bcol-2 btn wsprkl"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M5,25 45,25z M55,25 95,25zM5,40 45,40z M55,40 95,40zM5,55 45,55z M55,55 95,55zM5,70 45,70z M55,70 95,70z"></path></svg></a></div></div><div class="lol"><a class="" href="/books/NBK604921/?report=classic">Switch to classic view</a><a href="/books/NBK604921/pdf/Bookshelf_NBK604921.pdf">PDF (463K)</a><a href="/books/NBK604921/?report=printable">Print View</a></div></div></aside><aside id="jr-bkhelp-p" class="hidden flexv"><div class="tb sk-htbar flexh"><div><a class="jr-p-close btn wsprkl">Done</a></div><div class="title-text f1">Help</div></div><div class="cnt f1 lol"><a id="jr-helpobj-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/help.xml" href="">Help</a><a href="mailto:info@ncbi.nlm.nih.gov?subject=PubReader%20feedback%20%2F%20NBK604921%20%2F%20sid%3ACE8B5AF87C7FFCB1_0191SID%20%2F%20phid%3ACE8B5C3C7C8ED0910000000000380032.4">Send us feedback</a><a id="jr-about-sw" data-path="/corehtml/pmc/jatsreader/ptpmc_3.22/" data-href="/corehtml/pmc/jatsreader/ptpmc_3.22/img/bookshelf/about.xml" href="">About PubReader</a></div></aside><aside id="jr-objectbox" class="thidden hidden"><div class="jr-objectbox-close wsprkl">✘</div><div class="jr-objectbox-inner cnt"><div class="jr-objectbox-drawer"></div></div></aside><nav id="jr-pm-left" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Previous Page</text></svg></nav><nav id="jr-pm-right" class="hidden"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 40 800" preserveAspectRatio="none"><text font-stretch="ultra-condensed" x="800" y="-15" text-anchor="end" transform="rotate(90)" font-size="18" letter-spacing=".1em">Next Page</text></svg></nav><nav id="jr-fip" class="hidden"><nav id="jr-fip-term-p"><input type="search" placeholder="search this page" id="jr-fip-term" autocorrect="off" autocomplete="off" /><a id="jr-fip-mg" class="wsprkl btn" title="Find"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 550 600" preserveAspectRatio="none"><path fill="none" stroke="#000" stroke-width="36" stroke-linecap="round" style="fill:#FFF" d="m320,350a153,153 0 1,0-2,2l170,170m-91-117 110,110-26,26-110-110"></path></svg></a><a id="jr-fip-done" class="wsprkl btn" title="Dismiss find">✘</a></nav><nav id="jr-fip-info-p"><a id="jr-fip-prev" class="wsprkl btn" title="Jump to previuos match">◀</a><button id="jr-fip-matches">no matches yet</button><a id="jr-fip-next" class="wsprkl btn" title="Jump to next match">▶</a></nav></nav></div><div id="jr-epub-interstitial" class="hidden"></div><div id="jr-content"><article data-type="main"><div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><div class="fm-sec"><h1 id="_NBK604921_"><span class="label">NCL Method ITA-8.1</span><span class="title" itemprop="name">Chemotaxis Assay</span></h1><div class="subtitle whole_rhythm">Version 2</div><p class="contribs">Potter TM, Cedrone E, Neun BW, et al.</p><p class="fm-aai"><a href="#_NBK604921_pubdet_">Publication Details</a></p></div></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="ncipr46.s1"><h2 id="_ncipr46_s1_">1. Introduction</h2><p>This document provides a protocol for rapid, quantitative measure of the chemoattractant capacity of a nanoparticulate material. Leukocyte recruitment is a central component of the inflammatory process, both in physiological host defense and in a range of prevalent disorders with an inflammatory component. In response to a complex network of pro-inflammatory signaling molecules (including cytokines, chemokines and prostaglandins), circulating leukocytes migrate from the bloodstream to the site of inflammation.</p></div><div id="ncipr46.s2"><h2 id="_ncipr46_s2_">2. Principles</h2><p>This assay represents an <i>in vitro</i> model, in which promyelocytic leukemia cells (HL-60) are separated from control chemoattractant or test-nanoparticles by a 3 µm filter; the cell migration through the filter is then monitored by detection of cells migrated through the filter into the bottom chamber of the culture plate using the fluorescent dye Calcein AM.</p></div><div id="ncipr46.s3"><h2 id="_ncipr46_s3_">3. Reagents, Materials, Cell Lines, and Equipment</h2><blockquote><p><i>Note: The NCL does not endorse any of the suppliers listed below; these reagents were used in the development of the protocol and their inclusion is for informational purposes only. Equivalent supplies from alternate vendors can be substituted. Please note that suppliers may undergo a name change due to a variety of factors. Brands and part numbers typically remain consistent but may also change over time</i>.</p></blockquote><dl id="ncipr46.l1" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.1.</dt><dd id="ncipr46.lt1"><p class="no_top_margin">Reagents
|
|
<dl id="ncipr46.l2" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.1.1.</dt><dd id="ncipr46.lt2"><p class="no_top_margin">Phosphate buffered saline (PBS) (GE Life Sciences, Hyclone, SH30256.01)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.2.</dt><dd id="ncipr46.lt3"><p class="no_top_margin">Bovine serum albumin (BSA) (Sigma-Aldrich, A4503)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.3.</dt><dd id="ncipr46.lt4"><p class="no_top_margin">Fetal bovine serum (FBS) (GE Life Sciences, Hyclone, SH30070.03)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.4.</dt><dd id="ncipr46.lt5"><p class="no_top_margin">RPMI-1640 (GE Life Sciences, HyClone, SH30096.01)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.5.</dt><dd id="ncipr46.lt6"><p class="no_top_margin">Calcein AM (Molecular Probes, C3099)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.6.</dt><dd id="ncipr46.lt7"><p class="no_top_margin">Penicillin streptomycin solution (GE Life Sciences, Hyclone, SV30010)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.7.</dt><dd id="ncipr46.lt8"><p class="no_top_margin">Trypan Blue solution (Gibco, 15250-061)</p></dd></dl><dl class="bkr_refwrap"><dt>3.1.8.</dt><dd id="ncipr46.lt9"><p class="no_top_margin">L-glutamine (GE Life Sciences, Hyclone, SH30034.01)</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.2.</dt><dd id="ncipr46.lt10"><p class="no_top_margin">Materials
|
|
<dl id="ncipr46.l3" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.2.1.</dt><dd id="ncipr46.lt11"><p class="no_top_margin">Pipettes covering the range of 0.05 to 10 mL</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.2.</dt><dd id="ncipr46.lt12"><p class="no_top_margin">Multi-Screen-MIC 96-well filter plates with 3µm membrane (Millipore, MAMIC3S10)</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.3.</dt><dd id="ncipr46.lt13"><p class="no_top_margin">Multi-Screen 96-well culture tray (feeding tray) (Millipore, MAMCS9610)</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.4.</dt><dd id="ncipr46.lt14"><p class="no_top_margin">96 microwell Nunclon optical bottom plates (Nunc, 165305)</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.5.</dt><dd id="ncipr46.lt15"><p class="no_top_margin">Polypropylene tubes, 50 and 15 mL</p></dd></dl><dl class="bkr_refwrap"><dt>3.2.6.</dt><dd id="ncipr46.lt16"><p class="no_top_margin">Multichannel pipettor</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.3.</dt><dd id="ncipr46.lt17"><p class="no_top_margin">Cell Line
|
|
<dl id="ncipr46.l4" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.3.1.</dt><dd id="ncipr46.lt18"><p class="no_top_margin">HL-60 promyelocytic cells (ATCC, ATCC<sup>®</sup>-CCL-240™)</p></dd></dl></dl></p></dd></dl><dl class="bkr_refwrap"><dt>3.4.</dt><dd id="ncipr46.lt19"><p class="no_top_margin">Equipment
|
|
<dl id="ncipr46.l5" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>3.4.1.</dt><dd id="ncipr46.lt20"><p class="no_top_margin">Centrifuge capable of operating at 400xg</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.2.</dt><dd id="ncipr46.lt21"><p class="no_top_margin">Refrigerator, 2-8ºC</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.3.</dt><dd id="ncipr46.lt22"><p class="no_top_margin">Freezer, −20ºC</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.4.</dt><dd id="ncipr46.lt23"><p class="no_top_margin">Cell culture incubator with 5% CO<sub>2</sub> and 95% humidity</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.5.</dt><dd id="ncipr46.lt24"><p class="no_top_margin">Biohazard safety cabinet approved for level II handling of biological material</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.6.</dt><dd id="ncipr46.lt25"><p class="no_top_margin">Inverted microscope</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.7.</dt><dd id="ncipr46.lt26"><p class="no_top_margin">Vortex</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.8.</dt><dd id="ncipr46.lt27"><p class="no_top_margin">Hemocytometer</p></dd></dl><dl class="bkr_refwrap"><dt>3.4.9.</dt><dd id="ncipr46.lt28"><p class="no_top_margin">Multiwell plate reader capable of operating in fluorescence mode at 485 nm and 535 nm</p></dd></dl></dl></p></dd></dl></dl></div><div id="ncipr46.s4"><h2 id="_ncipr46_s4_">4. Reagent and Control Preparation</h2><dl id="ncipr46.l6" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>4.1.</dt><dd id="ncipr46.lt29"><p class="no_top_margin">
|
|
<u>Complete RPMI-1640 Medium</u>
|
|
</p><p>The complete RPMI medium should contain the following reagents:
|
|
<ul id="ncipr46.l7" class="simple-list"><li id="ncipr46.lt30" class="half_rhythm"><div>20% FBS (heat inactivated)</div></li><li id="ncipr46.lt31" class="half_rhythm"><div>4 mM L-glutamine</div></li><li id="ncipr46.lt32" class="half_rhythm"><div>100 U/mL penicillin</div></li><li id="ncipr46.lt33" class="half_rhythm"><div>100 µg/mL streptomycin sulfate</div></li></ul></p><p>Store at 2-8ºC protected from light for no longer than 1 month. Before use, warm in a water bath.</p></dd></dl><dl class="bkr_refwrap"><dt>4.2.</dt><dd id="ncipr46.lt34"><p class="no_top_margin">
|
|
<u>Starvation Media (SM)</u>
|
|
</p><p>The starving RPMI medium should contain the following reagents:
|
|
<ul id="ncipr46.l8" class="simple-list"><li id="ncipr46.lt35" class="half_rhythm"><div>0.2 % BSA</div></li><li id="ncipr46.lt36" class="half_rhythm"><div>4 mM L-glutamine</div></li><li id="ncipr46.lt37" class="half_rhythm"><div>100 U/mL penicillin</div></li><li id="ncipr46.lt38" class="half_rhythm"><div>100 µg/mL streptomycin sulfate</div></li></ul></p><p>Store at 2-8°C protected from light for no longer than 1 month. Before use, warm the medium in a water bath.</p></dd></dl><dl class="bkr_refwrap"><dt>4.3.</dt><dd id="ncipr46.lt39"><p class="no_top_margin">
|
|
<u>Heat-Inactivated Fetal Bovine Serum</u>
|
|
</p><p>Thaw a bottle of FBS at room temperature or overnight at 2-8ºC and allow to equilibrate to room temperature. Incubate 30 minutes at 56ºC in a water bath, mixing every 5 minutes. Single use aliquots may be stored at 2-8ºC for up to one month or at a nominal temperature of −20ºC indefinitely.</p></dd></dl><dl class="bkr_refwrap"><dt>4.4.</dt><dd id="ncipr46.lt40"><p class="no_top_margin">
|
|
<u>Positive Control</u>
|
|
</p><p>On the day of the experiment, dilute heat-inactivated FBS in serum-free medium supplemented with 0.2% BSA to a final concentration of 20%.</p></dd></dl><dl class="bkr_refwrap"><dt>4.5.</dt><dd id="ncipr46.lt41"><p class="no_top_margin">
|
|
<u>Negative Control</u>
|
|
</p><p>Use PBS as a negative control. Process this control the same way as your study samples.</p></dd></dl><dl class="bkr_refwrap"><dt>4.6.</dt><dd id="ncipr46.lt42"><p class="no_top_margin">
|
|
<u>Calcein AM (CAM) Working Solution</u>
|
|
</p><p>Calcein AM is supplied as a 1 mM solution. Dilute this stock solution in pre-warmed (37°C) 1X PBS to a final concentration of 4 µM (e.g. add 10 µL of stock Calcein AM to 2.49 mL of 1X PBS). The working dilution should be prepared and used <i>ex tempore</i>.</p></dd></dl><dl class="bkr_refwrap"><dt>4.7.</dt><dd id="ncipr46.lt43"><p class="no_top_margin">
|
|
<u>Vehicle Control</u>
|
|
</p><p>Vehicle control is the buffer or media used to formulate test nanomaterials. Common excipients used in nanoformulations are trehalose, sucrose, and albumin. However, other reagents and materials are also used alone or in combination.</p><p>Vehicle control should match formulation buffer of the test-nanomaterial by both composition and concentration. This control can be skipped if nanoparticles are stored in PBS.</p></dd></dl></dl></div><div id="ncipr46.s5"><h2 id="_ncipr46_s5_">5. Preparation of Study Samples</h2><p>This assay requires 3 mL of nanoparticles, at 1X the highest final tested concentration dissolved/resuspended in starvation medium. The concentration is selected based on the plasma concentration of the nanoparticle at the intended therapeutic dose. For the purpose of this protocol this concentration is called the “theoretical plasma concentration”. Considerations for estimating theoretical plasma concentration were reviewed elsewhere [<a class="bibr" href="#ncipr46.ref1" rid="ncipr46.ref1">1</a>] and are summarized in <a href="/books/NBK604921/box/ncipr46.box12/?report=objectonly" target="object" rid-ob="figobncipr46box12">Box 1</a> below.</p><div id="ncipr46.box12" class="box boxed-text-box whole_rhythm hide-overflow"><h3><span class="label">Box 1</span><span class="title">Example Calculation to Determine Nanoparticle Concentration for In Vitro Tests</span></h3><p>In this example, we assume a mouse dose of 123 mg/kg. Therefore, the scaled equivalent human dose would be:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq1"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr46.eq1" display="block"><mi>H</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi><mo>=</mo><mfrac><mrow><mi>m</mi><mi>o</mi><mi>u</mi><mi>s</mi><mi>e</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>123</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
Blood volume constitutes approximately 8% of the body weight. Therefore, an average human of 70 kg body weight has approximately 5.6 L of blood. Assuming all the nanoparticle injected goes into the systemic circulation, this provides a rough approximation of the potential maximum nanoparticle concentration in blood, which is used as the in vitro test concentration.</p><div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq2"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col">
|
|
<math id="ncipr46.eq2" display="block"><mi>i</mi><mi>n</mi><mtext> </mtext><mi>v</mi><mi>i</mi><mi>t</mi><mi>r</mi><mi>o</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>m</mi><mi>a</mi><mi>t</mi><mi>r</mi><mi>i</mi><mi>x</mi></mrow></msub><mo>=</mo><mfrac><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>b</mi><mi>l</mi><mi>o</mi><mi>o</mi><mi>d</mi><mtext> </mtext><mi>v</mi><mi>o</mi><mi>l</mi><mi>u</mi><mi>m</mi><mi>e</mi></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>70</mn><mtext> </mtext><mi>k</mi><mi>g</mi><mtext> </mtext><mo>∗</mo><mtext> </mtext><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>5.6</mn><mtext> </mtext><mi>L</mi></mrow></mfrac><mo>=</mo><mn>0.125</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>m</mi><mi>L</mi></math>
|
|
</div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></div><p>The assay will evaluate 4 concentrations: 10X (or when feasible 100X, 30X or 5X) of the theoretical plasma concentration, theoretical plasma concentration and two 1:5 serial dilutions of the theoretical plasma concentration. When the intended therapeutic concentration is unknown, the highest final concentration is 1 mg/mL or the highest reasonably achievable concentration.</p><p>For example, if the final theoretical plasma concentration to be tested is 0.2 mg/mL, then a stock of 2 mg/mL will be prepared and diluted 10-fold (0.2 mg/mL), followed by two 1:5 serial dilutions (0.04 and 0.008 mg/mL). Use 150 μL of each of these samples per well. Each nanoparticle concentration is plated three times.</p></div><div id="ncipr46.s6"><h2 id="_ncipr46_s6_">6. HL-60 Cell Preparation</h2><p>HL-60 is a promyelocytic cell line derived by S.J. Collins, et al. from a patient with acute promyelocytic leukemia [<a class="bibr" href="#ncipr46.ref2" rid="ncipr46.ref2">2</a>]. Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 1x10<sup>5</sup> viable cells/mL. Do not allow cell concentration to exceed 1x10<sup>6</sup> cells/mL. Maintain cell density between 1x10<sup>5</sup> and 1x10<sup>6</sup> viable cells/mL.</p><dl id="ncipr46.l9" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>6.1.</dt><dd id="ncipr46.lt44"><p class="no_top_margin">Expand cells until they are approximately 80-90% confluent (~3-5 days before experiment). Two days before the experiment, feed the cells following regular maintenance procedures.</p></dd></dl><dl class="bkr_refwrap"><dt>6.2.</dt><dd id="ncipr46.lt45"><p class="no_top_margin">One day before the experiment count cells using trypan blue. If the cell viability is at least 90%, pellet cells for 5 minutes at 400xg in a 15 mL tube.</p></dd></dl><dl class="bkr_refwrap"><dt>6.3.</dt><dd id="ncipr46.lt46"><p class="no_top_margin">Resuspend cells in Starvation Medium and incubate overnight (16-18 hr) at 37°C in a humidified incubator (95% air, 5% CO<sub>2</sub>).</p></dd></dl><dl class="bkr_refwrap"><dt>6.4.</dt><dd id="ncipr46.lt47"><p class="no_top_margin">On the day of experiment, count cells using trypan blue and adjust concentration to 1x10<sup>6</sup>
|
|
<b><u>viable</u></b> cells/mL in Starvation Medium.</p></dd></dl></dl></div><div id="ncipr46.s7"><h2 id="_ncipr46_s7_">7. Experimental Procedure</h2><p><i>The procedure described below is based on</i>
|
|
<a class="bibr" href="#ncipr46.ref3" rid="ncipr46.ref3">reference 3</a>.</p><dl id="ncipr46.l10" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>7.1.</dt><dd id="ncipr46.lt48"><p class="no_top_margin">Insert the filter plate into the feeding tray and set it aside.</p></dd></dl><dl class="bkr_refwrap"><dt>7.2.</dt><dd id="ncipr46.lt49"><p class="no_top_margin">Add 150 µL of starvation medium, positive control, negative control and test-nanomaterial in starvation medium into fresh feeding tray. Avoid generating bubbles while adding solutions to wells. Plate additional test-nanomaterial wells for use as cell-free controls (refer to plate map in <a href="#ncipr46.app">Appendix</a>).</p></dd></dl><dl class="bkr_refwrap"><dt>7.3.</dt><dd id="ncipr46.lt50"><p class="no_top_margin">Add 50 µL of cell suspension (prepared in <a href="#ncipr46.lt47">step 6.4</a>) per well of the Multi-Screen filter plate (50,000 cells per well) from <a href="#ncipr46.lt48">Step 7.1</a>. Avoid generating bubbles while adding cells to wells. Add 50 µL of media to the cell-free control wells.</p></dd></dl><dl class="bkr_refwrap"><dt>7.4.</dt><dd id="ncipr46.lt51"><p class="no_top_margin">Gently assemble Multi-Screen filter plate (<a href="#ncipr46.lt50">step 7.3</a>) and feeding tray containing controls and test particles (<a href="#ncipr46.lt49">step 7.2</a>). This is the <b>Assay Plate</b>. An example of the assay plate template is shown in the <a href="#ncipr46.app">Appendix</a>. Avoid shaking or tilting plates as it will disturb concentration gradient.</p></dd></dl><dl class="bkr_refwrap"><dt>7.5.</dt><dd id="ncipr46.lt52"><p class="no_top_margin">Cover the plate and incubate for 4 hr at 37°C in a humidified incubator (5% CO<sub>2</sub>, 95% air). During incubation, pre-warm PBS to 37°C and equilibrate the calcein AM to room temperature.</p></dd></dl><dl class="bkr_refwrap"><dt>7.6.</dt><dd id="ncipr46.lt53"><p class="no_top_margin">Prepare a working solution of Calcein AM (CAM) as described in <a href="#ncipr46.lt42">section 4.6</a> of the method.</p></dd></dl><dl class="bkr_refwrap"><dt>7.7.</dt><dd id="ncipr46.lt54"><p class="no_top_margin">After the 4 hr incubation, remove the chemotaxis assay plate from the incubator. As before, avoid shaking or tilting the plate.</p></dd></dl><dl class="bkr_refwrap"><dt>7.8.</dt><dd id="ncipr46.lt55"><p class="no_top_margin">Gently remove the Multi-Screen filter plate and discard it.</p></dd></dl><dl class="bkr_refwrap"><dt>7.9.</dt><dd id="ncipr46.lt56"><p class="no_top_margin">Add 50 µL of 1X PBS and 50 µL of CAM working solution to appropriate wells, and 150 µL of 1X PBS plus 50 µL of CAM working solution to the reagent background control wells on the feeding tray as outlined in the example template shown in the <a href="#ncipr46.app">Appendix</a>. This is the <b>Calcein Plate</b>. Incubate the plate for 1 hr at 37°C.</p></dd></dl><dl class="bkr_refwrap"><dt>7.10.</dt><dd id="ncipr46.lt57"><p class="no_top_margin">Transfer 180 µL of solution from the Calcein Plate to corresponding wells on a Nunc optical bottom plate and read the Nunc plate on a fluorescent plate reader at 485 nm excitation/535 nm emission.</p></dd></dl></dl></div><div id="ncipr46.s8"><h2 id="_ncipr46_s8_">8. Calculations</h2><dl id="ncipr46.l11" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>8.1.</dt><dd id="ncipr46.lt58"><p class="no_top_margin">A percent coefficient of variation (CV) should be calculated for each control or test according to the following formula:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq3"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr46.eq3" display="block"><mrow><mi>%</mi><mi>C</mi><mi>V</mi><mo>=</mo><mfrac><mrow><mi>s</mi><mi>t</mi><mi>a</mi><mi>n</mi><mi>d</mi><mi>a</mi><mi>r</mi><mi>d</mi><mtext> </mtext><mi>d</mi><mi>e</mi><mi>v</mi><mi>i</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><mi>n</mi></mrow><mrow><mi>m</mi><mi>e</mi><mi>a</mi><mi>n</mi></mrow></mfrac><mo>∗</mo><mn>100</mn><mi>%</mi></mrow></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></p></dd></dl><dl class="bkr_refwrap"><dt>8.2.</dt><dd id="ncipr46.lt59"><p class="no_top_margin">Background Chemotaxis
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq4"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr46.eq4" display="block"><mrow><mi>B</mi><mi>a</mi><mi>c</mi><mi>k</mi><mi>g</mi><mi>r</mi><mi>o</mi><mi>u</mi><mi>n</mi><mi>d</mi><mtext> </mtext><mi>C</mi><mi>h</mi><mi>e</mi><mi>m</mi><mi>o</mi><mi>t</mi><mi>a</mi><mi>x</mi><mi>i</mi><mi>s</mi><mo>=</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>S</mi><mi>M</mi><mo>/</mo><mi>C</mi><mi>A</mi><mi>M</mi><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub><mo>−</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>S</mi><mi>M</mi><mo>/</mo><mi>P</mi><mi>B</mi><mi>S</mi><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub><mo>−</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>r</mi><mi>e</mi><mi>a</mi><mi>g</mi><mi>e</mi><mi>n</mi><mi>t</mi><mtext> </mtext><mi>b</mi><mi>a</mi><mi>c</mi><mi>k</mi><mi>g</mi><mi>r</mi><mi>o</mi><mi>u</mi><mi>n</mi><mi>d</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>o</mi><mi>l</mi><mtext> </mtext><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub></mrow></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></p></dd></dl><dl class="bkr_refwrap"><dt>8.3.</dt><dd id="ncipr46.lt60"><p class="no_top_margin">Sample Chemotaxis
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq5"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr46.eq5" display="block"><mrow><mi>S</mi><mi>a</mi><mi>m</mi><mi>p</mi><mi>l</mi><mi>e</mi><mtext> </mtext><mi>C</mi><mi>h</mi><mi>e</mi><mi>m</mi><mi>o</mi><mi>t</mi><mi>a</mi><mi>x</mi><mi>i</mi><mi>s</mi><mo>=</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>T</mi><mi>S</mi><mo>/</mo><mi>C</mi><mi>A</mi><mi>M</mi><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub><mo>−</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>S</mi><mi>M</mi><mo>/</mo><mi>P</mi><mi>B</mi><mi>S</mi><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub><mo>−</mo><mi>M</mi><mi>e</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>F</mi><msub><mi>U</mi><mrow><mi>r</mi><mi>e</mi><mi>a</mi><mi>g</mi><mi>e</mi><mi>n</mi><mi>t</mi><mtext> </mtext><mi>b</mi><mi>a</mi><mi>c</mi><mi>k</mi><mi>g</mi><mi>r</mi><mi>o</mi><mi>u</mi><mi>n</mi><mi>d</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>o</mi><mi>l</mi><mtext> </mtext><mi>w</mi><mi>e</mi><mi>l</mi><mi>l</mi><mi>s</mi></mrow></msub></mrow></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></p></dd></dl><dl class="bkr_refwrap"><dt>8.4.</dt><dd id="ncipr46.lt61"><p class="no_top_margin">Comparison of sample chemotaxis to background chemotaxis is performed to evaluate chemotactic potential of test material. In general, fold chemotaxis induction equal to or greater than 2 is considered positive. Statistical methods such as Student’s t-test should be applied to evaluate the significance of difference between background chemotaxis and that of test-sample.</p></dd></dl></dl></div><div id="ncipr46.s9"><h2 id="_ncipr46_s9_">9. Acceptance Criteria</h2><dl id="ncipr46.l12" class="temp-labeled-list"><dl class="bkr_refwrap"><dt>9.1.</dt><dd id="ncipr46.lt62"><p class="no_top_margin">%CV for each control and test sample should be less than 30%.</p></dd></dl><dl class="bkr_refwrap"><dt>9.2.</dt><dd id="ncipr46.lt63"><p class="no_top_margin">If two of three replicates of positive control or negative control fail to meet acceptance criterion described in 9.1, the assay should be repeated.</p></dd></dl><dl class="bkr_refwrap"><dt>9.3.</dt><dd id="ncipr46.lt64"><p class="no_top_margin">Within the acceptable assay, if two of three replicates of unknown sample fail to meet acceptance criterion described in 9.1, this unknown sample should be re-analyzed.</p></dd></dl></dl></div><div id="ncipr46.rl.r1"><h2 id="_ncipr46_rl_r1_">10. References</h2><dl class="temp-labeled-list"><dl class="bkr_refwrap"><dt>1.</dt><dd><div class="bk_ref" id="ncipr46.ref1">Dobrovolskaia
|
|
MA, McNeil
|
|
SE. Understanding the correlation between in vitro and in vivo immunotoxicity tests for nanomedicines. J Control Release. 2013;172(2):456–66.
|
|
[<a href="/pmc/articles/PMC5831149/" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pmc">PMC free article<span class="bk_prnt">: PMC5831149</span></a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23742883" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 23742883</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>2.</dt><dd><div class="bk_ref" id="ncipr46.ref2">Gallagher
|
|
R, et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. Blood
|
|
54: 713–733, 1979.
|
|
[<a href="https://pubmed.ncbi.nlm.nih.gov/288488" ref="pagearea=cite-ref&targetsite=entrez&targetcat=link&targettype=pubmed">PubMed<span class="bk_prnt">: 288488</span></a>]</div></dd></dl><dl class="bkr_refwrap"><dt>3.</dt><dd><div class="bk_ref" id="ncipr46.ref3">Kamath
|
|
L. Multi-Screen-MIC Application note. Lit# AN1060EN00, Millipore Life Science Division.</div></dd></dl></dl></div><div id="ncipr46.s10"><h2 id="_ncipr46_s10_">11. Abbreviations</h2><dl><dt id="ncipr46.abb_DL1_DI1">BSA</dt><dd><p>bovine serum albumin</p></dd><dt id="ncipr46.abb_DL1_DI2">CAM</dt><dd><p>Calcein AM</p></dd><dt id="ncipr46.abb_DL1_DI3">CV</dt><dd><p>coefficient of variation</p></dd><dt id="ncipr46.abb_DL1_DI4">FBS</dt><dd><p>fetal bovine serum</p></dd><dt id="ncipr46.abb_DL1_DI5">FU</dt><dd><p>fluorescence units</p></dd><dt id="ncipr46.abb_DL1_DI6">PBS</dt><dd><p>phosphate buffered saline</p></dd><dt id="ncipr46.abb_DL1_DI7">RBC</dt><dd><p>Reagent background control</p></dd><dt id="ncipr46.abb_DL1_DI8">RPMI</dt><dd><p>Roswell Park Memorial Institute</p></dd><dt id="ncipr46.abb_DL1_DI9">SD</dt><dd><p>standard deviation</p></dd><dt id="ncipr46.abb_DL1_DI10">SM</dt><dd><p>starvation media</p></dd><dt id="ncipr46.abb_DL1_DI11">VC</dt><dd><p>vehicle control</p></dd></dl></div><div id="ncipr46.app"><h2 id="_ncipr46_app_">12. Appendix</h2><div id="ncipr46.app.fig1" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Assay%20Plate%20Map.&p=BOOKS&id=604921_ncipr46appf1.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img src="/books/NBK604921/bin/ncipr46appf1.jpg" alt="Example Assay Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Assay Plate Map</span></h3><div class="caption"><p>This is the template for the feeding tray. Wells in rows A-F in the upper filter plate receive 50,000 cells in 50 µL.</p><p>Row H are the cell-free test samples; they do not receive cells.</p><p>SM: Starvation Medium; NC: Negative Control; PC: Positive Control; TS: Test Sample; VC: Vehicle Control</p></div></div><div id="ncipr46.app.fig2" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Calcein%20Plate%20Map.&p=BOOKS&id=604921_ncipr46appf2.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img src="/books/NBK604921/bin/ncipr46appf2.jpg" alt="Example Calcein Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Calcein Plate Map</span></h3><div class="caption"><p>PBS: 50 µL PBS</p><p>CAM: 50 µL Calcein AM</p><p>RBC: Reagent Background Control, 150 µL PBS + 50 µL Calcein AM</p></div></div></div><div><dl class="temp-labeled-list small"><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin"><p>This protocol assumes an intermediate level of scientific competency with regard to techniques, instrumentation, and safety procedures. Rudimentary assay details have been omitted for the sake of brevity.</p></p></div></dd></dl><dl class="bkr_refwrap"><dt>*</dt><dd><div id="ncipr46.fn1"><p class="no_top_margin">address correspondence to: <a href="mailto:dev@null" data-email="vog.hin.liam@aniram" class="oemail">vog.hin.liam@aniram</a></p></div></dd></dl><dl class="bkr_refwrap"><dt></dt><dd><div><p class="no_top_margin"><div>
|
|
<span class="mixed-citation" id="ncipr46.suggestedcitation">Potter TW, Cedrone E, Neun BW, Dobrovolskaia MA, NCL Method ITA-8.1: Chemotaxis Assay. <a href="https://ncl.cancer.gov/resources/assay-cascade-protocols" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">https://ncl.cancer.gov/resources/assay-cascade-protocols</a> DOI: <a href="http://dx.crossref.org/10.17917/CPWX-SP39" ref="pagearea=body&targetsite=external&targetcat=link&targettype=uri">10.17917/CPWX-SP39</a></span>
|
|
</div></p></div></dd></dl></dl></div><div id="bk_toc_contnr"></div></div></div><div class="fm-sec"><h2 id="_NBK604921_pubdet_">Publication Details</h2><h3>Author Information and Affiliations</h3><p class="contrib-group"><h4>Authors</h4><span itemprop="author">Timothy M. Potter</span>, <span itemprop="author">Edward Cedrone</span>, <span itemprop="author">Barry W. Neun</span>, and <span itemprop="author">Marina A. Dobrovolskaia</span><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1</sup>.</p><h4>Contact</h4><div class="affiliation"><sup>1</sup> <span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@aniram" class="oemail">vog.hin.liam@aniram</a></div><div class="affiliation"><sup>1</sup> Nanotechnology Characterization Lab, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute, Frederick, MD 21702</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><h3>Publication History</h3><p class="small">Published: <span itemprop="datePublished">May 2020</span>.</p><h3>Copyright</h3><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div></div><h3>Publisher</h3><p><a href="https://www.cancer.gov/nano/research/ncl" ref="pagearea=page-banner&targetsite=external&targetcat=link&targettype=publisher">National Cancer Institute (US)</a>, Bethesda (MD)</p><h3>NLM Citation</h3><p>Potter TM, Cedrone E, Neun BW, et al. Chemotaxis Assay: Version 2. 2020 May. In: National Cancer Institute’s Nanotechnology Characterization Laboratory Assay Cascade Protocols [Internet]. Bethesda (MD): National Cancer Institute (US); 2005 May 1-. NCL Method ITA-8.1.<span class="bk_cite_avail"></span> doi: 10.17917/CPWX-SP39</p></div><div class="small-screen-prev"><a href="/books/n/nciprotocols/ncipr47/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M75,30 c-80,60 -80,0 0,60 c-30,-60 -30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Prev</text></svg></a></div><div class="small-screen-next"><a href="/books/n/nciprotocols/ncipr45/?report=reader"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100" preserveAspectRatio="none"><path d="M25,30c80,60 80,0 0,60 c30,-60 30,0 0,-60"></path><text x="20" y="28" textLength="60" style="font-size:25px">Next</text></svg></a></div></article><article data-type="boxed-text" id="figobncipr46box12"><div id="ncipr46.box12" class="box boxed-text-box whole_rhythm hide-overflow"><h3><span class="label">Box 1</span><span class="title">Example Calculation to Determine Nanoparticle Concentration for In Vitro Tests</span></h3><p>In this example, we assume a mouse dose of 123 mg/kg. Therefore, the scaled equivalent human dose would be:
|
|
<div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq1"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col"><math id="ncipr46.eq1" display="block"><mi>H</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi><mo>=</mo><mfrac><mrow><mi>m</mi><mi>o</mi><mi>u</mi><mi>s</mi><mi>e</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>123</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>12.3</mn></mrow></mfrac><mo>=</mo><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></math></div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div>
|
|
Blood volume constitutes approximately 8% of the body weight. Therefore, an average human of 70 kg body weight has approximately 5.6 L of blood. Assuming all the nanoparticle injected goes into the systemic circulation, this provides a rough approximation of the potential maximum nanoparticle concentration in blood, which is used as the in vitro test concentration.</p><div class="pmc_disp_formula whole_rhythm clearfix" id="ncipr46.deq2"><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow twelve_col">
|
|
<math id="ncipr46.eq2" display="block"><mi>i</mi><mi>n</mi><mtext> </mtext><mi>v</mi><mi>i</mi><mi>t</mi><mi>r</mi><mi>o</mi><mtext> </mtext><mi>c</mi><mi>o</mi><mi>n</mi><mi>c</mi><mi>e</mi><mi>n</mi><mi>t</mi><mi>r</mi><mi>a</mi><mi>t</mi><mi>i</mi><mi>o</mi><msub><mi>n</mi><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>m</mi><mi>a</mi><mi>t</mi><mi>r</mi><mi>i</mi><mi>x</mi></mrow></msub><mo>=</mo><mfrac><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>d</mi><mi>o</mi><mi>s</mi><mi>e</mi></mrow><mrow><mi>h</mi><mi>u</mi><mi>m</mi><mi>a</mi><mi>n</mi><mtext> </mtext><mi>b</mi><mi>l</mi><mi>o</mi><mi>o</mi><mi>d</mi><mtext> </mtext><mi>v</mi><mi>o</mi><mi>l</mi><mi>u</mi><mi>m</mi><mi>e</mi></mrow></mfrac><mo>=</mo><mfrac><mrow><mn>70</mn><mtext> </mtext><mi>k</mi><mi>g</mi><mtext> </mtext><mo>∗</mo><mtext> </mtext><mn>10</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>k</mi><mi>g</mi></mrow><mrow><mn>5.6</mn><mtext> </mtext><mi>L</mi></mrow></mfrac><mo>=</mo><mn>0.125</mn><mtext> </mtext><mi>m</mi><mi>g</mi><mo>/</mo><mi>m</mi><mi>L</mi></math>
|
|
</div><div class="inline_block pmc_inline_block pmc_va_middle pmc_hide_overflow last bk_equ_label "><div><span class="nowrap"></span></div></div></div></div></article><article data-type="fig" id="figobncipr46appfig1"><div id="ncipr46.app.fig1" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Assay%20Plate%20Map.&p=BOOKS&id=604921_ncipr46appf1.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img data-src="/books/NBK604921/bin/ncipr46appf1.jpg" alt="Example Assay Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Assay Plate Map</span></h3><div class="caption"><p>This is the template for the feeding tray. Wells in rows A-F in the upper filter plate receive 50,000 cells in 50 µL.</p><p>Row H are the cell-free test samples; they do not receive cells.</p><p>SM: Starvation Medium; NC: Negative Control; PC: Positive Control; TS: Test Sample; VC: Vehicle Control</p></div></div></article><article data-type="fig" id="figobncipr46appfig2"><div id="ncipr46.app.fig2" class="figure bk_fig"><div class="graphic"><a href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Example%20Calcein%20Plate%20Map.&p=BOOKS&id=604921_ncipr46appf2.jpg" target="tileshopwindow" class="inline_block pmc_inline_block ts_canvas img_link" title="Click on image to zoom"><div class="ts_bar small" title="Click on image to zoom"></div><img data-src="/books/NBK604921/bin/ncipr46appf2.jpg" alt="Example Calcein Plate Map." class="tileshop" title="Click on image to zoom" /></a></div><h3><span class="title">Example Calcein Plate Map</span></h3><div class="caption"><p>PBS: 50 µL PBS</p><p>CAM: 50 µL Calcein AM</p><p>RBC: Reagent Background Control, 150 µL PBS + 50 µL Calcein AM</p></div></div></article></div><div id="jr-scripts"><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/libs.min.js"> </script><script src="/corehtml/pmc/jatsreader/ptpmc_3.22/js/jr.min.js"> </script><script type="text/javascript" src="/core/mathjax/2.7.9/MathJax.js?config=TeX-AMS-MML_SVG"> </script></div></div>
|
|
|
|
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js"> </script>
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal104 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3968615.js" snapshot="books"></script></body>
|
|
</html>
|